US Markets

Gilead to pay $97 million to resolve kickback claims -U.S. Justice Department

Credit: REUTERS/Mike Blake

Gilead Sciences Inc has agreed to pay $97 million to resolve claims that it illegally used a foundation as a conduit to pay the copays of thousands of Medicare patients taking Gilead's pulmonary arterial hypertension drug Letairis, the Justice Department said on Wednesday.

WASHINGTON, Sept 23 (Reuters) - Gilead Sciences Inc GILD.O has agreed to pay $97 million to resolve claims that it illegally used a foundation as a conduit to pay the copays of thousands of Medicare patients taking Gilead's pulmonary arterial hypertension drug Letairis, the Justice Department said on Wednesday.

(Reporting by Mohammad Zargham)

((mohammad.zargham@thomsonreuters.com;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

GILD

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More